From the Journals

Invasive bacterial infections uncommon in afebrile infants with diagnosed AOM


 

FROM PEDIATRICS

The findings are not generalizable to infants aged younger than 28 days

Finally, the authors cautioned that because the number of infants younger than 28 days was quite small, and it is therefore infinitely more challenging to diagnose AOM for these patients, results of the study should be applied to infants older than 28 days and are not generalizable to febrile infants.

“This report will not resolve the significant challenge faced by clinicians in treating infants aged [younger than] 28 days who have the highest risk of occult bacteremia and systemic spread of a focal bacterial infection,” Joseph Ravera, MD, and M.W. Stevens, MD, of the University of Vermont, Burlington, noted in an accompanying editorial. Previous studies have identified this age group “to be at the highest risk for systemic bacterial involvement and the most difficult to risk stratify on the basis of physical examination findings and initial laboratory results,” they noted. That the subjects aged younger than 28 days in this study had nearly a 50% admission rate illustrates the clinical uncertainty pediatric emergency medicine providers are challenged with, they added. Just 100 (6%) of the 1,637 patients in the study sample were in this age category, which makes it difficult, given the lack of sufficient data, to generalize findings to the youngest infants.

“Despite a paucity of young infants and limitations inherent to the design, this study does contribute to the literature with a robust retrospective data set of afebrile infants between 1 and 3 months of age with an ED diagnosis of AOM ... It certainly provides a base of support for carefully designed prospective studies in which researchers aim to determine the best care for AOM in children under 6 months of age,” reflected Dr. Ravera and Dr. Stevens.

In a separate interview, Karalyn Kinsella, MD, private practice, Cheshire, Conn. noted, “What is confusing is the absence of documented symptoms for infants presenting to the emergency department, as the symptoms they presented with would influence our concern for IBI. Diagnosing AOM in infants under 90 days old is extremely uncommon as an outpatient pediatrician. Although the finding of AOM in an afebrile infant is very rare in the outpatient setting, this study assures us the risk of IBI is almost nonexistent. Therefore, further workup is unnecessary unless providers have clinical suspicions to the contrary.”

Dr. McLaren and colleagues as well as Dr. Ravera, Dr. Stevens, and Dr. Kinsella, had no conflicts of interest and no relevant financial disclosures.

Pages

Recommended Reading

Current PERISCOPE vaccine studies: Toward better pertussis prevention?
Clinician Reviews
Seeking new vaccines against whooping cough: The PERISCOPE project
Clinician Reviews
Getting closer to a lifesaving RSV vaccine
Clinician Reviews
HPV vaccine appears effective for treating warts, particularly in children
Clinician Reviews
New pediatric cases down as U.S. tops 2 million children with COVID-19
Clinician Reviews
Bariatric surgery might reduce severity of COVID-19 infection
Clinician Reviews
Expanding Verrucous Plaque on the Face
Clinician Reviews
Risk of HPV-related oropharyngeal cancer linked to number of oral sex partners
Clinician Reviews
Updated USPSTF HBV screening recommendation may be a ‘lost opportunity’
Clinician Reviews
COVID-19 in children: Weekly cases trending downward
Clinician Reviews